Information:
Error:
ID
19381
Description
Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose; ODM derived from: https://clinicaltrials.gov/show/NCT00145353
Link
https://clinicaltrials.gov/show/NCT00145353
Keywords
Versions (1)
- 12/27/16 12/27/16 -
Uploaded on
December 27, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 1 Diabetes Mellitus NCT00145353
Eligibility Type 1 Diabetes Mellitus NCT00145353
- StudyEvent: Eligibility
Similar models
Eligibility Type 1 Diabetes Mellitus NCT00145353
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
insulin treatment Insulin-Dependent Diabetes Mellitus | Basal insulin Bolus Dosing Unit Daily Frequency
Item
type 1 diabetes mellitus treated with insulin four times daily (basal bolus treatment) at least three months before screening.
boolean
C0745343 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
C0650607 (UMLS CUI [2,1])
C1705509 (UMLS CUI [2,2])
C0332173 (UMLS CUI [2,3])
C0376249 (UMLS CUI [2,4])
C0011854 (UMLS CUI [1,2])
C0650607 (UMLS CUI [2,1])
C1705509 (UMLS CUI [2,2])
C0332173 (UMLS CUI [2,3])
C0376249 (UMLS CUI [2,4])
Age
Item
age: 18-60 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
bmi: 18-27.5
boolean
C1305855 (UMLS CUI [1])
Kidney Diseases | Neuropathy | Creatinine measurement, serum | Monofilament pressure perception test Normal
Item
no nefro- or neuropathy; i.e. s-creatinin below 120 μmol/l and normal monofilament examination
boolean
C0022658 (UMLS CUI [1])
C0442874 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C1609492 (UMLS CUI [4,1])
C0205307 (UMLS CUI [4,2])
C0442874 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C1609492 (UMLS CUI [4,1])
C0205307 (UMLS CUI [4,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Pregnancy | Pregnancy, Planned
Item
pregnant women or patients planning to become pregnant during the investigation period
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0032992 (UMLS CUI [2])
Deteriorating vision | Visual Acuity Ophthalmic examination and evaluation
Item
reduced eyesight; i.e. visus > 0.3 evaluated at the latest eye exam.
boolean
C0558171 (UMLS CUI [1])
C0042812 (UMLS CUI [2,1])
C0200149 (UMLS CUI [2,2])
C0042812 (UMLS CUI [2,1])
C0200149 (UMLS CUI [2,2])
Insulin Sensitivity Ability Lacking
Item
patient lacking the ability to sens insulin sensitivity
boolean
C0920563 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0085732 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
Comorbidity Serious | Heart Diseases | Hepatic Insufficiency Severe | lung; insufficiency Severe | Mental disorders Severe
Item
serious rival disease, i.e. heart disease, severe liver or lung impairment, severe psychiatric disease.
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2])
C1306571 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C1401064 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0004936 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C0205404 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2])
C1306571 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C1401064 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0004936 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
Substance Use Disorders Suspicion | Compliance behavior Limited Suspicion
Item
suspicion of abuse or non-compliance
boolean
C0038586 (UMLS CUI [1,1])
C0242114 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0242114 (UMLS CUI [2,3])
C0242114 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0242114 (UMLS CUI [2,3])
Study Subject Participation Status
Item
participation in another clinical trial
boolean
C2348568 (UMLS CUI [1])